TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11430394

Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 200
Study: 9743085

Group type: EXPERIMENTAL
Intervention: Uvulopalatopharyngoplasty
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Laser palatoplasty
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Diathermy palatoplasty
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 62
Study: 7849144

Group type: EXPERIMENTAL
Intervention: Misoprostol 600 mg/day for 6 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 36
Study: 3381712

Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg twice daily for 3 months)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ketotifen (1 mg twice daily for 5 months)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo (5 months)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Ketotifen (5 months)
Number of subjects: 75
Study: 29982583

Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 0.4 to 0.6 mg/kg body weight
Number of subjects: 47
Study: 28818031

Group type: EXPERIMENTAL
Intervention: Danggui Buxue Decoction (DBD)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 89
Study: 24978159

Group type: EXPERIMENTAL
Intervention: Sleep problems at baseline (43% reported sleep problems, n = 215)
Number of subjects: 499

Group type: COMPARATOR
Intervention: No sleep problems at baseline (57% did not report sleep problems, n = 284)
Number of subjects: 499

Group type: EXPERIMENTAL
Intervention: Continued sleep problems
Number of subjects: 499
Study: 23153942

Group type: EXPERIMENTAL
Intervention: Continuous irrigation with an outflow of water (group 3)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Continuous irrigation without an outflow of water (group 2)
Number of subjects: 36

Group type: COMPARATOR
Intervention: No irrigation (group 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Flexible cystoscopy with NCIS
Number of subjects: 36

Group type: COMPARATOR
Intervention: Flexible cystoscopy without NCIS
Number of subjects: 36
Study: 22052306

Group type: EXPERIMENTAL
Intervention: Multiplexed 1,440 and 1,320 nm fractionated laser treatment
Number of subjects: 20
Study: 20225467

Group type: EXPERIMENTAL
Intervention: Conditioned for 7 days at 37 degrees C in 75% ethanol aqueous solution
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Immersed in fluoride gel (Elmex Gelée) at 37 degrees C for 1 hour
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Simulated toothbrushing with an electric toothbrush while being immersed in toothpaste
Number of subjects: 36
Study: 17036705

Group type: EXPERIMENTAL
Intervention: Crest Dual Action Whitening Toothpaste
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control anti-caries dentifrice
Number of subjects: 24
Study: 14607663

Group type: EXPERIMENTAL
Intervention: 10 mg morphine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 15 mg anisodamine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 0.75 mg atropine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 20 mg buscopan
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 10695694

Group type: EXPERIMENTAL
Intervention: Behavioral intervention addressing consistent condom use, reducing alcohol consumption, brothel patronage, and improving sexual negotiation and condom skills.
Number of subjects: 450

Group type: COMPARATOR
Intervention: Control group (distant camps)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Behavioral intervention
Number of subjects: 450
Study: 9502522

Group type: EXPERIMENTAL
Intervention: Injured soldiers (30 with permanent disabling injuries)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Injured soldiers (30 with nondisabling injuries)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Noninjured soldiers
Number of subjects: 90

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 90
Study: 8384952

Group type: EXPERIMENTAL
Intervention: Local nervous blockade with bupivacaine (5 mg/ml) subcutaneously injected (15 ml)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control experiments without local nervous blockade
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Local nervous blockade with bupivacaine
Number of subjects: 10
Study: 3529000

Group type: EXPERIMENTAL
Intervention: labetalol 400 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 31218636

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure treatment (systolic BP target: 110‐139 mmHg)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Standard blood pressure treatment (systolic BP target: 140‐179 mmHg)
Number of subjects: 195
Study: 30538533

Group type: EXPERIMENTAL
Intervention: Interspinous process decompression (IPD) with the Superion Indirect Decompression System
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Interspinous process decompression (IPD)
Number of subjects: 190
Study: 27549354

Group type: EXPERIMENTAL
Intervention: Wheat meal (low viscosity, 0.042 Pa s)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oatmeal (high viscosity, 0.266 Pa s)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: High nutrient wheat meal
Number of subjects: 10
Study: 24185211

Group type: EXPERIMENTAL
Intervention: True acupuncture
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 100
Study: 22863164

Group type: EXPERIMENTAL
Intervention: Exercise and sauna
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sauna alone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control period
Number of subjects: 16
Study: 20347840

Group type: EXPERIMENTAL
Intervention: Massage therapy (20-minute session between postoperative days 2 and 5)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard care (20-minute quiet time between postoperative days 2 and 5)
Number of subjects: 58
Study: 18366572

Group type: EXPERIMENTAL
Intervention: Automated pegboard (APB 2000) test for unimpaired participants performing normally
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Automated pegboard (APB 2000) test for individuals with shoulder pain
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Automated pegboard (APB 2000) test for unimpaired participants feigning shoulder pain
Number of subjects: 21
Study: 15840102

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) 1% cm(‐2) applied twice daily for 4 days
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulphate (SLS) 0.5% cm(‐2) applied twice daily for 4 days
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Combination of cold and SLS (SLS 1% or 0.5%) applied twice daily for 4 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Cold exposure alone (4 degrees C for 90 s or 15 degrees C for 10 min)
Number of subjects: 32
Study: 12416768

Group type: EXPERIMENTAL
Intervention: Chlorhexidine treatment (0.12% local irrigation and gel)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Mechanical cleansing and oral hygiene instructions (Control group)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Mechanical cleansing alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Mechanical debridement supplemented with chlorhexidine
Number of subjects: 16
Study: 10484800

Group type: EXPERIMENTAL
Intervention: Proportional Assist (PA)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Assist/Control (A/C)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Intermittent Mandatory Ventilation (IMV)
Number of subjects: 36
Study: 9177613

Group type: EXPERIMENTAL
Intervention: Progestin-estrogen therapy (group I, 96 patients)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Antihypertensive drugs (group II, 84 patients)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Progestin-estrogen therapy (for 23 unresponsive patients from group II)
Number of subjects: 180
Study: 1726458

Group type: EXPERIMENTAL
Intervention: Cyclosporine, OKT3, and Euro-Collins preservation period (January 1984 to September 1987)
Number of subjects: 2090

Group type: EXPERIMENTAL
Intervention: University of Wisconsin solution preservation period (October 1987 to December 1988)
Number of subjects: 2090

Group type: EXPERIMENTAL
Intervention: FK506 period (January 1989 to December 1990)
Number of subjects: 2090

Group type: COMPARATOR
Intervention: Patients in critical condition
Number of subjects: 2090
Study: 6275829

Group type: EXPERIMENTAL
Intervention: Naturally occurring dietary fibre (salad vegetables and apple)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Simple sugars and starch added to a gelatine and cream cheese base (control)
Number of subjects: 25
Study: 31107412

Group type: EXPERIMENTAL
Intervention: Positive Affect Induction (watching movie clips for 15 mins)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Neutral Affect Induction (watching movie clips for 15 mins)
Number of subjects: 147
Study: 28093466

Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan 200 mg
Number of subjects: 454

Group type: COMPARATOR
Intervention: Olmesartan 20 mg
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 454
Study: 25887580

Group type: EXPERIMENTAL
Intervention: Short colonic reservoir (observation group)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Long colonic reservoir (control group)
Number of subjects: 81
Study: 23186035

Group type: EXPERIMENTAL
Intervention: GEn 1,200 mg/day
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: GEn 2,400 mg/day
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: GEn 3,600 mg/day
Number of subjects: 421

Group type: COMPARATOR
Intervention: PGB 300 mg/day
Number of subjects: 421

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 421
Study: 21092934

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavior therapy (CBT) for IBS based on exposure and mindfulness exercises
Number of subjects: 75
Study: 19696680

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Head-down positioning
Number of subjects: 20
Study: 17137560

Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER 20 mg
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER 30 mg
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER 40 mg
Number of subjects: 221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: d‐MPH‐ER (all doses)
Number of subjects: 221
Study: 15102869

Group type: EXPERIMENTAL
Intervention: 4 mg dose of montelukast oral granules
Number of subjects: 32

Group type: COMPARATOR
Intervention: 10 mg film-coated tablet (FCT) in adults
Number of subjects: 32
Study: 12234056

Group type: EXPERIMENTAL
Intervention: DOMS exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hypertonic saline injection (5 x 200 microl 5.8% NaCl)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control leg (no treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline injection
Number of subjects: 0
Study: 9661616

Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (1,000 micrograms/day, every 12 hours for 14 days)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo inhaler
Number of subjects: 25
Study: 7621734

Group type: EXPERIMENTAL
Intervention: Telecommunication system for outpatient management, self-monitoring blood glucose data transmitted by modem every 2 weeks, reviewed by nurse practitioners
Number of subjects: 106

Group type: COMPARATOR
Intervention: Standard care with regimen adjustments made by physicians
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Telecommunication system for outpatient management
Number of subjects: 106
Study: 2651567

Group type: EXPERIMENTAL
Intervention: Low/slow bromocriptine regimen (maximum 25 mg/day)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: High/fast bromocriptine regimen (maximum 100 mg/day)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Low/slow bromocriptine regimen
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: High/fast bromocriptine regimen
Number of subjects: 134
Study: 175693

Group type: EXPERIMENTAL
Intervention: Combined treatment with radiation therapy and 5-Fluorouracil
Number of subjects: 136

Group type: COMPARATOR
Intervention: Radiation therapy alone
Number of subjects: 136
Study: 31375426

Group type: EXPERIMENTAL
Intervention: Soluble fibre (inulin 12 g/day)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Soluble fibre + probiotic (inulin 12 g/day + multi-strain probiotic >25 billion CFU)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 29466222

Group type: EXPERIMENTAL
Intervention: Clinical algorithm (individual patient characteristics)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard method
Number of subjects: 60
Study: 24337896

Group type: EXPERIMENTAL
Intervention: Bismuth iodoform paraffin paste pack
Number of subjects: 32

Group type: COMPARATOR
Intervention: No ear pack
Number of subjects: 32
Study: 24516951

Group type: EXPERIMENTAL
Intervention: 500 mg oral lincomycin + high fiber (L + F)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo + high fiber (P + F)
Number of subjects: 0
Study: 22282954

Group type: EXPERIMENTAL
Intervention: Test formulation of clopidogrel 75 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference formulation of clopidogrel 75 mg
Number of subjects: 24
Study: 20055193

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.7 microg x kg(‐1) x hr(‐1) after a bolus infusion at 6.0 microg x kg(‐1) x hr(‐1) for 10 min)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no dexmedetomidine)
Number of subjects: 24
Study: 16715977

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Minimally-invasive cholecystectomy
Number of subjects: 100
Study: 15355582

Group type: EXPERIMENTAL
Intervention: Cognitive therapy
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Psychodynamic therapy
Number of subjects: 121
Study: 11694026

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 829

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 829

Group type: COMPARATOR
Intervention: Nimesulide and Paracetamol
Number of subjects: 829

Group type: COMPARATOR
Intervention: Chronic Urticaria History
Number of subjects: 829

Group type: COMPARATOR
Intervention: NSAID-induced Urticaria/Angioedema History
Number of subjects: 829
Study: 9389266

Group type: EXPERIMENTAL
Intervention: Isoflurane
Number of subjects: 13

Group type: COMPARATOR
Intervention: Propofol and alfentanil
Number of subjects: 13
Study: 8187303

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment (0.02‐0.05 IU/kg body weight subcutaneously at bedtime)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 40
Study: 3129593

Group type: EXPERIMENTAL
Intervention: 1‐mg daily intravenous injection of vitamin K
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 10‐mg weekly intramuscular injection of vitamin K
Number of subjects: 60

Group type: COMPARATOR
Intervention: No vitamin K (28 patients from earlier study)
Number of subjects: 60
Study: 30655636

Group type: EXPERIMENTAL
Intervention: Deprox® (flower pollen extracts)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Bioflavonoids (quercetin)
Number of subjects: 54
Study: 28460286

Group type: EXPERIMENTAL
Intervention: Maternal traumatic exposure
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Individual traumatic exposure
Number of subjects: 378

Group type: EXPERIMENTAL
Intervention: Lifetime traumatic exposure of mothers
Number of subjects: 378
Study: 24583757

Group type: EXPERIMENTAL
Intervention: PUFA (eicosapentaenoic acid 2160 mg and docosahexaenoic acid 1440 mg daily)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (isocaloric corn oil)
Number of subjects: 37
Study: 22985391

Group type: EXPERIMENTAL
Intervention: 10 mL of 2% lidocaine and then 10 mL of 0.75% ropivacaine (Group lr)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 mL of normal saline and then 10 mL of 0.75% ropivacaine (Group r)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10 mL of 2% lidocaine and then 10 mL of 0.75% ropivacaine (Group LR)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 mL of normal saline and then 10 mL of 0.75% ropivacaine (Group R)
Number of subjects: 40
Study: 21330041

Group type: EXPERIMENTAL
Intervention: 0.2 mg kg(‐1) adrenaline
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.2 U kg(‐1) vasopressin
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 0.8 U kg(‐1) vasopressin
Number of subjects: 21
Study: 19236498

Group type: EXPERIMENTAL
Intervention: microS+TCD ultrasound (sonolysis)
Number of subjects: 0

Group type: COMPARATOR
Intervention: saline+brief TCD vessel assessments
Number of subjects: 0
Study: 17059437

Group type: EXPERIMENTAL
Intervention: cilostazol (200 mg p.o.)
Number of subjects: 12

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 12
Study: 14564321

Group type: EXPERIMENTAL
Intervention: Tirofiban plus heparin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 0
Study: 10964333

Group type: EXPERIMENTAL
Intervention: Psychosocial group intervention (6-week structured program including health education, coping skills training, stress management, and psychologic support)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 151
Study: 8985780

Group type: EXPERIMENTAL
Intervention: Intracavernous injection (ICI) of 20 micrograms/mL PGE1
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Intracavernous injection (ICI) of 25 micrograms/mL PGE1
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cocktail containing 20 micrograms PGE1 plus 0.5 mg/mL phentolamine
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Cocktail containing 25 micrograms PGE1 plus 0.5 mg/mL phentolamine
Number of subjects: 34
Study: 1297297

Group type: EXPERIMENTAL
Intervention: rt-PA (100 mg/90 minutes; 10 mg bolus + 90 mg/90 minutes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: rt-PA
Number of subjects: 50
Study: 6342151

Group type: EXPERIMENTAL
Intervention: Thoracic duct drainage
Number of subjects: 11

Group type: COMPARATOR
Intervention: Peritoneal dialysis
Number of subjects: 11
Study: 31146534

Group type: EXPERIMENTAL
Intervention: Rilpivirine Long Acting (RPV LA) 1,200 mg
Number of subjects: 12
Study: 29718715

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (bup/nal) treatment
Number of subjects: 133

Group type: COMPARATOR
Intervention: Out-of-bup/nal-treatment group
Number of subjects: 133
Study: 27142044

Group type: EXPERIMENTAL
Intervention: Octenidine dihydrochloride (OCT)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Benzalkonium chloride (BAC)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both groups (OCT and BAC)
Number of subjects: 110
Study: 25310185

Group type: EXPERIMENTAL
Intervention: irinotecan+5-fluorouracil/leucovorin (IFL)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: 5-fluorouracil/leucovorin (FU/LV)
Number of subjects: 1264
Study: 22956348

Group type: EXPERIMENTAL
Intervention: recombinant FSH supplemented by 100 IU hCG
Number of subjects: 73

Group type: COMPARATOR
Intervention: recombinant FSH alone
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: recombinant FSH supplemented by 200 IU hCG
Number of subjects: 73
Study: 19423612

Group type: EXPERIMENTAL
Intervention: Nicotine-containing cigarette
Number of subjects: 0

Group type: COMPARATOR
Intervention: Denicotinised cigarette
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-abstinent condition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Abstinent condition
Number of subjects: 0
Study: 17852781

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (diet and physical activity)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 11704083

Group type: EXPERIMENTAL
Intervention: Oral misoprostol (two doses of 400 microg taken 2 h apart)
Number of subjects: 1168

Group type: COMPARATOR
Intervention: Vaginal misoprostol (one dose of 800 microg)
Number of subjects: 1168
Study: 9231214

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin, 15 mg/kg/d for 2 days
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Oral ofloxacin, 10 mg/kg/d for 3 days
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Nalidixic acid resistant strains of S. typhi
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Nalidixic acid sensitive isolates of S. typhi
Number of subjects: 107
Study: 8430925

Group type: EXPERIMENTAL
Intervention: Formoterol 12 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Procaterol 25 micrograms
Number of subjects: 12
Study: 3120440

Group type: EXPERIMENTAL
Intervention: Partusisten long term tocolysis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol short term tocolysis
Number of subjects: 0
Study: 31167545

Group type: EXPERIMENTAL
Intervention: Acceptance-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cognitive reappraisal-based intervention
Number of subjects: 0
Study: 29580298

Group type: EXPERIMENTAL
Intervention: Submental liposuction
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 20
Study: 27765714

Group type: EXPERIMENTAL
Intervention: Individualized functional restoration incorporating advice (10 sessions)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Guideline‐based advice alone (2 sessions)
Number of subjects: 54
Study: 26513847

Group type: EXPERIMENTAL
Intervention: Home-based oral care training program
Number of subjects: 94

Group type: COMPARATOR
Intervention: Routine oral care education with swabs (Control)
Number of subjects: 94
Study: 23680334

Group type: EXPERIMENTAL
Intervention: Tapering of antihypertensive medications over 3 weeks (week 1: reduction by 25%-50%; week 2: 50%-75%; week 3: off)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Tapering of antihypertensive medications
Number of subjects: 53